Dodging The September Slump: Inside The 2026 IPO Rebound

The 2026 IPO market has logged 331 new filings and 280 completed offerings year-to-date, already surpassing full Q1-Q3 2025 levels, while withdrawals have fallen to just 10 from 157 during the 2022 rate shock. Anthropic is reportedly targeting October to avoid September seasonality and key inflation and Fed-rate events, potentially opening the window for other mega-cap AI listings, including OpenAI, before year-end. The sharp improvement in issuance and withdrawal activity signals a materially healthier IPO backdrop.

Analysis

The key transmission is from issuance volume to risk appetite, not primary-fee revenue alone. Nasdaq (NDAQ), NYSE parent ICE, and underwriting leaders GS/MS/JPM gain immediately through listing, trading, and advisory activity, but the larger 6-18 month beneficiary is private-asset monetization: BX, KKR, APO and TPG can mark portfolios higher, realize exits, and recycle capital into new funds. A functioning exit market also reduces the probability that late-stage venture investors become forced sellers, supporting private-company valuations and AI infrastructure spending.

The near-term market risk is absorption. A concentrated wave of large, cash-burning AI listings could pull liquidity from listed software and semiconductors, particularly expensive long-duration names in IGV and cloud/security cohorts, before any fundamental demand effect appears. In the next 1-3 months, the relevant test is whether new issues price above range and hold gains through the first two weeks; weak aftermarket performance would rapidly widen issuance discounts and shut the window for lower-quality sponsors.

Consensus may be too focused on a single marquee issuer. The more durable signal would be broadening into sponsor-backed industrial, healthcare and financial-services exits, which carries greater implications for alternative managers' distributable earnings than a handful of AI offerings. Conversely, an AI-only window would indicate speculative demand rather than a normalized capital-markets cycle; it could increase index-level concentration and leave public software vulnerable to multiple compression as investors rotate toward fresh-growth supply.

The main falsifiers are a sustained rise in real yields, renewed inflation upside, or consecutive poorly performing large IPOs. Monitor IPO ETF IPO relative to QQQ, average first-week returns, deal upsizing frequency, and alt-manager commentary on realizations; deterioration in these measures matters more than headline filing counts.

Key Decisions for Investors

• Initiate a 3-6 month basket long BX/KKR/APO versus short IGV in equal dollar amounts. The thesis is exit-driven fee-related earnings and realization upside at alternatives managers versus valuation and liquidity pressure on high-multiple public software; reassess if IPO ETF IPO underperforms QQQ by more than 10% over four weeks or real yields rise materially.
• Overweight NDAQ and ICE for 1-3 months ahead of the seasonal issuance window, with a preference for NDAQ where incremental technology-listing and trading sensitivity is higher. Size modestly: fee upside is likely visible only in subsequent reporting periods, while a risk-off tape can overwhelm operating leverage in the near term.
• Use GS and MS as tactical long candidates only after evidence that large deals are pricing at or above the indicated range and trading above issue price after one week. This avoids paying for an underwriting-cycle recovery before deal economics are independently validated; exit on a broad deal-repricing sequence or a material rates shock.
• Avoid chasing pre-IPO AI proxies or broad IPO-beta through late-stage enthusiasm. Set an alert to reassess a long IPO ETF position only if new-issue aftermarket breadth remains positive across multiple sectors for 4-6 weeks; absent that breadth, the risk/reward favors listed beneficiaries of issuance rather than the newly issued securities themselves.